Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma

  1. Mateos, M.V.
  2. Cibeira, M.T.
  3. Richardson, P.G.
  4. Prosper, F.
  5. Oriol, A.
  6. De La Rubia, J.
  7. Lahuerta, J.J.
  8. García-Sanz, R.
  9. Extremera, S.
  10. Szyldergemajn, S.
  11. Corrado, C.
  12. Singer, H.
  13. Mitsiades, C.S.
  14. Anderson, K.C.
  15. Bladé, J.
  16. San Miguel, J.
Revue:
Clinical Cancer Research

ISSN: 1078-0432 1557-3265

Année de publication: 2010

Volumen: 16

Número: 12

Pages: 3260-3269

Type: Article

DOI: 10.1158/1078-0432.CCR-10-0469 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable